drugset / Trial / NCT03158779
Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
The aim of this phase II study is to assess the efficacy and safety of sequentially integrated treatment of FOLFIRINOX or Gemcitabine-Abraxane and SBRT in patients with unresectable pancreatic cancer.
Timeline
- Start
- 2017-05-10
- Primary completion
- 2022-07-01
- Completion
- 2022-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abraxane | Small molecule | — | — |
| Subject | Gemcitabine | Small molecule | — | — |